"Designing Growth Strategies is in our DNA"

Blood Group Typing Market Size, Share & Industry Analysis, By Product (Instruments, and Reagents & Kits), By Test Type (ABO Tests, Antigen Typing, Antibody Screening, Cross-matching Tests, and HLA Typing), By Techniques (Serology Tests, and Molecular Tests), By End User (Hospital-based Laboratories, and Independent Laboratories & Blood Banks), and Regional Forecast, 2020-2027

Region : Global | Format: PDF | Report ID: FBI101767

 

KEY MARKET INSIGHTS

Play Audio Listen to Audio Version

This report covers COVID-19 impact analysis on Blood Group Typing Market

Inquire before buying

Blood group typing is a laboratory-based procedure used to identify an individual’s blood type. It is grouped according to the ABO system and consist of four types i.e. A, B, C, AB, and type O. These tests are critical prior to procedures such as blood transfusion and blood donation. It is attested by several incidences that not all blood types are compatible and thus, such procedures require pre-transfusion blood group typing to determine the presence of antigens, antibodies, and compatibility between donor and recipient’s blood. Blood typing tests are very significant tests during the time of pregnancy to prevent hemolytic anemia in the newborns (HDN). Hence, rising demand for prenatal testing during pregnancy has augmented the adoption of blood group typing globally. The COVID-19 global pandemic has presented unprecedented challenges to the blood group typing market growth in 2020.

MARKET TRENDS

Request a sample to learn more about this report.

Introduction of Advanced and Automated Technologies for Blood Typing to Drive the Blood Group Typing Market Growth

Blood transfusions require mandatory antibody screening and cross-match testing to examine the compatibility between donor and recipient blood groups. Market players are focusing on introduction of new type of tests based on innovative techniques offering results in reduced turn-around time, with improved accuracy and efficiency in cross-match tests, and antibody screening. Hence, the introduction of automated systems and advanced molecular blood group typing techniques have been instrumental in boosting the adoption of blood testing systems, offering a huge opportunity for this market growth.

MARKET DRIVERS

Increasing Number of Blood Donations and Transfusions to Fuel the Demand for Blood Group Typing

According to the World Health Organization (WHO), globally in 2018, an estimated 117.4 million blood donations were collected. Various for-profit and not-for-profit organizations, domestic organizations, regional and national governments, and other agencies have been emphasizing the importance of blood donation. These organizations are also creating awareness among general population and encouraging voluntary blood donations in different countries. Rising incidence of accidents, and increasing number of patients suffering from cancer is propelling the demand for blood transfusions worldwide. For instance, according to The American National Red Cross, it was estimated that in every 2 seconds someone in the U.S needs blood transfusion. According to Community Blood Center, nearly 43,000 pints of donated blood is used each day in the U.S., and Canada. These conditions are generating a high demand for blood transfusions and subsequently driving the growth of this market globally.

MARKET RESTRAINT

Drastic Reduction in Number of Voluntary Blood Donations during COVID-19

The outbreak of COVID-19 among general population has resulted in an extreme decline in the number of voluntary blood donations globally. Donor centers in many developed and emerging countries have experienced a downfall in blood donations due to social distancing norms and cancellation of blood drives. Additionally, maintaining an adequate blood supply is vital to public health, accident victims, and patients suffering from chronic diseases such as cancer, etc. For instance, according to the American Red Cross, about 2,700 blood drives across the U.S have been cancelled due to the spread of COVID-19, which has resulted in drop of 86,000 blood donations. This is projected to exert an impact on this market growth in 2020.

Lack of Infrastructure and Skilled Professionals in Developing Countries to Hinder Growth

Despite increasing number of accident cases globally and rising prevalence of chronic diseases in emerging economies, there are certain factors hindering the growth of this market. Among them is lack of expenditure on healthcare infrastructure in emerging countries for blood group typing procedures. Also, lack of awareness about blood transfusion safety and dearth of skilled professionals are some of the major factors that have limited the adoption of blood group typing tests and instruments in these countries. 

SEGMENTATION

By Product Analysis

To know how our report can help streamline your business, Speak to Analyst

Reagents & Kits to Grow at Faster Pace during 2020-2027 Period

In terms of product, the market is segmented into instruments and reagents & kits. The instruments segment is projected to expand at a slower pace during the forecast period. Reusable nature of these instruments and longer shelf life associated with it are some of the factors attributed to the comparatively lower CAGR of the segment. However, the reagents & kits segment dominated the market in 2019.

By Test Type Analysis

Antibody Screening Segment Dominated the Market in 2019

Based on test type, the market is segmented into ABO tests, antigen typing, antibody screening, cross matching tests, and HLA typing. The antibody screening segment held the dominant share of the global market in 2019. The dominance of this segment is attributable to the increasing demand for early diagnosis and rising prevalence of blood transfusion related diseases worldwide. The ABO tests accounted for second largest share of the market in the year 2019 owing to regulations making it mandatory to use these tests for blood grouping during blood transfusion. Besides, antigen typing, cross-matching tests, and HLA typing segments accounted for comparatively lower share of the market in 2019.

By Techniques Analysis

Molecular Tests Segment to Register a Higher CAGR during the Forecast Period

Based on techniques, the market is segmented into serology tests and molecular tests. Serology tests are used to determine the blood group type, presence of Rh factor, and reaction between antibody and erythrocytes. Growing adoption of assay-based techniques for blood group typing, coupled with comparatively lower costs associated with these tests, are responsible for higher adoption of tests based on serology technique in developing countries.

However, introduction of molecular tests such as PCR and microarray-based techniques in the global market for blood group typing, and its growing popularity for blood typing are the key factors responsible for the comparatively higher CAGR of the segment during the forecast period.

By End User Analysis

Independent Laboratories & Blood Banks Segment Dominated the Market in 2019

In terms of end user, the market is segmented into hospital-based laboratories and independent laboratories & blood banks. The independent laboratories & blood banks segment is expected to have a dominant share in the market during the forecast period. The dominance is due to growing investments by private sectors leading to rise in the number of blood banks and stand-alone laboratories in developed and emerging countries, and growing number of patients being tested in these settings.

Besides, hospital-based laboratories segment is expected to register a significant growth during forecast period, owing to many hospitals worldwide implementing various programs to facilitate blood donations in these settings. This has led to growing demand for testing kits and instruments from these settings in 2019.

REGIONAL ANALYSIS

North America Blood Group Typing Market Size, 2019 (USD Million)

To get more information on the regional analysis of this market, Request a sample

The market size in North America stood at USD 572.0 million in 2019. The dominance of this region is attributed to growing voluntary blood donors, increasing demand of blood transfusion, and higher adoption of blood typing tests. This, combined with well-established regulatory framework in the U.S., and Canada, has been instrumental in the dominance of North America in the blood group typing market share. The market in Europe is expected to grow at a significant CAGR in the forecast period owing to rising awareness about blood safety and increasing demand of pre-transfusion tests coupled with high adoption of advanced blood typing technologies in the region. Increasing investment by key players in the emerging market of Asia-Pacific is anticipated to drive the demand for blood typing tests in the region during the forecast period. Latin America and the Middle East & Africa are expected to witness a comparatively lower CAGR in the forecast period owing to the lack of awareness among general population about blood transfusion safety and presence of huge underpenetrated markets in both of these regions.

KEY INDUSTRY PLAYERS

Major Players to Emphasize on Developing Novel Technologies for Blood Group Typing

Key players such as Grifols, S.A. and Bio-Rad Laboratories, Inc. are currently focused on developing novel tests and technologies during transfusion process. For instance, in October 2018 Grifols, received approval from the U.S FDA for ID Core XT molecular diagnostic test, which is used for red blood group typing. Additionally, the market players are also emphasizing on introduction of products that are capable of reducing workload of blood testing in laboratories. For instance, Bio-Rad Laboratories, Inc. launched IH-1000 blood typing system in the U.S market. This system offers full automation and walk-away reliability, allowing laboratories to manage their blood testing workload at lower prices.

Other key players such as Merck KGaA, QUOTIENT, Immucor, Inc., Beckman Coulter, Inc., Ortho Clinical Diagnostics, and Agena Bioscience have also entered in this market competition with advanced blood group typing tests and instruments. This is anticipated to positively impact the market growth as these companies are expected to increase their market share during the forecast period.

LIST OF KEY COMPANIES PROFILED:

KEY INDUSTRY DEVELOPMENTS:

  • October 2017 – the U.S Food and Drug Administration (FDA) approved Ortho Clinical Diagnostics, Inc. blood grouping reagents for extended phenotype testing procedures.
  • January 2019 – Grifols, S.A. received approval from the U.S Food and Drug Administration (FDA) for its fully automated analyzer Erytra Eflexis. This system performs pre-transfusion compatibility testing efficiently by using DG Gel technology.

REPORT COVERAGE

The blood group typing market report provides a detailed analysis of the market and focuses on key aspects such as leading companies, product types, and leading applications of the product. Besides this, the report offers insights into the market trends and highlights key industry developments. In addition to the aforementioned factors, the report encompasses several factors that have contributed to the growth of the market over the recent years.

To gain extensive insights into the market, Request for Customization

Report Scope & Segmentation

 ATTRIBUTE

 DETAILS

Study Period

  2016-2027

Base Year

  2019

Forecast Period

  2020-2027

Historical Period

  2016-2018

Unit

  Value (USD billion)

Segmentation

By Product

  • Instruments
  • Reagents & Kits

By Test Type

  • ABO Tests
  • Antigen Typing
  • Antibody Screening
  • Cross-matching Tests
  • HLA Typing

By Techniques

  • Serology Tests
  • Molecular Tests

By End User

  • Hospital-based Laboratories
  • Independent Laboratories & Blood Banks

By Geography

  • North America (U.S. and Canada)
  • Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
  • Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia- Pacific)
  • Latin America (Brazil, Mexico, and Rest of Latin America)
  • Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

 


Frequently Asked Questions

Fortune Business Insights says that the global market size was USD 1.53 billion in 2019 and is projected to reach USD 2.68 billion by 2027.

In 2019, the North America market value stood at USD 572.0 million.

Growing at a CAGR of 7.2%, the market will exhibit steady growth in the forecast period (2020-2027).

Reagents & kits segment is expected to be the leading segment in this market during the forecast period.

Increasing number of blood donations and number of blood transfusion is fuelling this market demand.

Grifols, S.A., Bio-Rad Laboratories, Inc., and QUOTIENT are major players of the global market.

North America dominated the market share in 2019.

Launch of advanced systems and technologies by market players and increasing demand of blood transfusion are expected to drive the adoption.

Blood Group Typing Market Size, Share and Global Industry Trend Forecast till 2026
  • May, 2020
  • 2019
  • 2016-2018
  • 125

    CHOOSE LICENSE TYPE

  • 4850
    6850
    8850

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info.
X